Maria Rita Bongiorno

13PUBLICATIONS
63CO-AUTHORS
AllergyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)NanometrologyHistory and theory of the built environment (excl. architecture)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Feb 19, 2026
Psychological Well-Being of Patients with Moderate-to-Severe Plaque Psoriasis Treated with Tildrakizumab: 28-Week Interim Results from a Multicenter Observational Study in Italy Using the DASS-21 Questionnaire, the BLUE Study.

Emanuele Trovato, Claudio Bonifati, Simone Ribero

|Jun 26, 2024
Effectiveness of guselkumab in patients with facial and/or genital psoriasis: Interim analysis results at Week 12 from the GULLIVER study.

C Bonifati, S Lembo, A G Richetta

|Apr 05, 2023
Lengthening the time intervals between doses of dupilumab in remission atopic dermatitis.

Giovanna Tilotta, Maria Rita Bongiorno

|Jul 27, 2022
TGF-β/VEGF-A Genetic Variants Interplay in Genetic Susceptibility to Non-Melanocytic Skin Cancer.

Letizia Scola, Maria Rita Bongiorno, Giusi Irma Forte

|Feb 15, 2022
Dual Inhibition of Myc Transcription and PI3K Activity Effectively Targets Colorectal Cancer Stem Cells.

Miriam Gaggianesi, Laura Rosa Mangiapane, Chiara Modica

|Aug 27, 2021
Nobiletin and Xanthohumol Sensitize Colorectal Cancer Stem Cells to Standard Chemotherapy.

Alice Turdo, Antonino Glaviano, Giacomo Pepe

Pageof 3

Frequent Collaborators

2 joint publications

Marco Romanelli

2 joint publications

Simone Di Franco

2 joint publications

Claudio Guarneri

2 joint publications

Laura Rosa Mangiapane